
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Well-heeled American Corporations Have Long Had A Financial Stake In Undermining Scientific Consensus And Manufacturing Uncertainty. In The Triumph Of Doubt, Former Obama And Clinton Official David Michaels Details How Corrupt Science Becomes Public Policy -- And Where It's Happening Today. Opioids. Concussions. Obesity. Climate Change. America Is A Country Of Everyday Crises -- Big, Long-spanning Problems That Persist Despite Their Toll On The Country's Health. And For Every Case Of Government Inaction On One Of These Issues, There Is A Set Of Familiar, Doubtful Refrains: The Science Is Unclear. The Data Are Inconclusive. Regulation Is Unjustified. It's A Slippery Slope. Is It? The Triumph Of Doubt Traces The Ascendance Of Science-for-hire In American Life And Government, From Its Origins In The Tobacco Industry In The 1950s To Its Current Manifestations Across Government, Public Policy, And Even Professional Sports. Amid Fraught Conversations Of Alternative Facts And Truth Decay, The Triumph Of Doubt Wields Its Unprecedented Access To Shine A Light On The Machinations And Scope Of Manipulated Science In American Society. It Is An Urgent, Revelatory Work, One That Promises To Reorient Conversations Around Science And The Public Good For The Foreseeable Future.
This book investigates how corporate interests systematically manufacture scientific uncertainty to influence public policy and delay regulation. David Michaels, an epidemiologist and former high-ranking government official, utilizes his extensive experience in regulatory agencies to document the rise of 'science-for-hire.' He argues that the playbook developed by the tobacco industry to obscure health risks has been adopted by various sectors, including the pharmaceutical, chemical, and sports industries, to protect profits at the expense of public health.
What You Will Find
Scope Limits
Experts and reviewers frequently cite this work as a critical examination of the intersection between corporate lobbying and scientific integrity. Readers often note the author's clear, accessible prose despite the technical nature of the regulatory and scientific issues discussed.
Page Count:
336
Publication Date:
2020-01-01
Publisher:
Oxford University Press
ISBN-10:
0190922672
ISBN-13:
9780190922672
No comments yet. Be the first to share your thoughts!